Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment

Intern Emerg Med. 2021 Mar;16(2):519-520. doi: 10.1007/s11739-020-02373-5. Epub 2020 May 21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / adverse effects
  • Antiviral Agents / therapeutic use
  • COVID-19*
  • Heparin / adverse effects
  • Humans
  • SARS-CoV-2*

Substances

  • Anticoagulants
  • Antiviral Agents
  • Heparin